Response by Figtree et al to Letter Regarding Article, "Canagliflozin and Heart Failure in Type 2 Diabetes Mellitus: Results From the CANVAS Program (Canagliflozin Cardiovascular Assessment Study)"

Gemma A Figtree^{1

2

3}, Karin Rådholm^{3

4

5

6}, Bruce Neal³

Affiliations

¹ Kolling Institute, Royal North Shore Hospital, Sydney, Australia (G.A.F.).
² Department of Medicine and Health, University of Sydney, Australia (G.A.F.).
³ The George Institute for Global Health, University of New South Wales, Sydney, Australia (G.A.F., K.R., B.N.).
⁴ Department of Medicine and Health Sciences, Division of Community Medicine, Primary Care, Faculty of Health Sciences, County Council of Östergötland, Linköping University, Sweden (K.R.).
⁵ Department of Medicine, University of New South Wales, Sydney, Australia (K.R.).
⁶ Imperial College London, UK (K.R.).

Free article

Comment

Gemma A Figtree et al. Circulation. 2019.

Free article

. 2019 Jan 15;139(3):418-419.

doi: 10.1161/CIRCULATIONAHA.118.038477.

Gemma A Figtree^{1

2

3}, Karin Rådholm^{3

4

5

6}, Bruce Neal³

¹ Kolling Institute, Royal North Shore Hospital, Sydney, Australia (G.A.F.).
² Department of Medicine and Health, University of Sydney, Australia (G.A.F.).
³ The George Institute for Global Health, University of New South Wales, Sydney, Australia (G.A.F., K.R., B.N.).
⁴ Department of Medicine and Health Sciences, Division of Community Medicine, Primary Care, Faculty of Health Sciences, County Council of Östergötland, Linköping University, Sweden (K.R.).
⁵ Department of Medicine, University of New South Wales, Sydney, Australia (K.R.).
⁶ Imperial College London, UK (K.R.).

No abstract available

Comment on

Canagliflozin and Heart Failure in Type 2 Diabetes Mellitus: Results From the CANVAS Program.
Rådholm K, Figtree G, Perkovic V, Solomon SD, Mahaffey KW, de Zeeuw D, Fulcher G, Barrett TD, Shaw W, Desai M, Matthews DR, Neal B. Rådholm K, et al. Circulation. 2018 Jul 31;138(5):458-468. doi: 10.1161/CIRCULATIONAHA.118.034222. Circulation. 2018. PMID: 29526832 Free PMC article. Clinical Trial.
Letter by Koh Regarding Article, "Canagliflozin and Heart Failure in Type 2 Diabetes Mellitus: Results From the CANVAS Program (Canagliflozin Cardiovascular Assessment Study)".
Koh KK. Koh KK. Circulation. 2019 Jan 15;139(3):416-417. doi: 10.1161/CIRCULATIONAHA.118.037209. Circulation. 2019. PMID: 30640544 No abstract available.